Suggestions
Jacques Bernier
Managing Partner at Teralys Capital
Jacques Bernier is a prominent Canadian entrepreneur and venture capitalist, known for his significant contributions to the high-tech and biotechnology sectors. He currently serves as the Managing Partner and Co-founder of Teralys Capital, a venture capital firm that focuses on investing in innovative companies, particularly in the life sciences and technology fields. His career spans over 35 years, during which he has played a pivotal role in shaping the landscape of technological innovation in Canada.23
Professional Background
- Board Memberships: Bernier has been a member of the Board of Directors for the Institut de recherche en immunologie et en cancérologie (IRIC) since January 2015 and has served on the board of IRICoR since June 2016. His involvement with these organizations underscores his commitment to advancing next-generation therapies and drug discovery initiatives.13
- Previous Roles: Before his current role at Teralys Capital, he was the Senior Vice-President at the Fonds de solidarité FTQ, where he was instrumental in supporting various emerging companies.34 He also held leadership positions, including President of Aventis Canada, where he contributed to the pharmaceutical sector's development in Canada.3
Education
Bernier holds a Bachelor's degree in Industrial Engineering from École Polytechnique de Montréal, which provides him with a strong foundation in engineering principles that he applies to his business ventures.35
Contributions and Recognition
Jacques Bernier is recognized not only for his business acumen but also for his philanthropic efforts and his active role in various boards, including those related to innovation and entrepreneurship in Montreal. His leadership is characterized by a focus on fostering innovation and collaboration between academia and industry to accelerate the development of new therapies.25
Overall, Jacques Bernier's extensive experience and dedication make him a key figure in driving advancements in healthcare and technology through strategic investments and governance.
